Boston Scientific
Выбор редакции
22 марта, 17:41

Boston Scientific to Buy NxThera, Strengthens Urology Arm

Even after the NxThera purchase deal culminates, it is not likely to add stimulus to Boston Scientific's (BSX) adjusted earnings per share through 2020 and prove to be accretive only later.

22 марта, 16:35

Can Boston Scientific's Pain be a Boon for Edwards & Others?

Boston Scientific delaying the re-introduction of Lotus Valve devices provides an edge to its competitors in the highly lucrative TAVR market.

21 марта, 17:48

Boston Scientific's Positive Trial Results to Boost EP Unit

Boston Scientific (BSX) forges ahead with initiatives to strengthen its hold in the high-potential EP market.

Выбор редакции
Выбор редакции
21 марта, 12:48

Boston Scientific to buy NxThera for up to $406 mln, including $306 mln in upfront cash payment

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

20 марта, 16:38

Goldman Sachs Backs Emerging Markets: MedTech Stocks in Focus

According to Goldman Sachs, emerging markets are world's best investment in spite of several external hiccups. This comes as a breather for MedTech investors keen on exposure to emerging markets.

13 марта, 17:29

Will Artificial Intelligence be a Trump Card for MedTech?

The strategic application of AI in every sphere of healthcare can provide an impetus to productivity rapidly.

09 марта, 23:26

3 Stocks to Gain as Trump Pulls Plug on Infamous MedTech Tax

Here take a quick look on three major MedTech companies that are going to make the best out of the recent Tax-Repeal upheaval.

06 марта, 17:16

Company News For Mar 6, 2018

Companies in the news are: YY,XL,BSX,WMT

06 марта, 17:14

Boston Scientific Acquires EMcision, Boosts Endoscopy Unit

Boston Scientific (BSX) adopts initiatives to strengthen the Endoscopy business.

Выбор редакции
01 марта, 18:09

Zacks Industry Outlook Highlights: Abbott, Becton and Dickinson, Stryker, Varian Medical and Boston Scientific

Zacks Industry Outlook Highlights: Abbott, Becton and Dickinson, Stryker, Varian Medical and Boston Scientific

01 марта, 00:59

MedTech's Long-Term Prospects Outweigh Near-Term Risks

MedTech's Long-Term Prospects Outweigh Near-Term Risks

28 февраля, 16:31

Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific

Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific

28 февраля, 00:16

Medical Device Industry Outlook - February 2018

Medical Device Industry Outlook - February 2018

07 февраля, 02:21

Millipede to Aid Boston Scientific, LOTUS Relaunch Lag Ails

Boston Scientific's (BSX) major Millipede investment might cement the company's position in the emerging mitral regurgitation field under its structural heart business.

02 февраля, 00:14

Boston Scientific (BSX) Q4 Earnings In Line, Revenues Top

In Q4, Boston Scientific (BSX) registers balanced growth across all business lines and geographies.

01 февраля, 15:55

Boston Scientific's (BSX) Q4 Earnings In Line, Sales Top

Boston Scientific (BSX) has posted impressive fourth quarter results by delivering revenue growth across all segments in Q4.

Выбор редакции
01 февраля, 14:53

Boston Scientific expects 2018 adj. EPS of $1.35 to $1.39; FactSet consensus $1.38

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.